On 2026-03-26, SpyGlass Pharma, Inc. (SGP) announced earnings per share of -5.72 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of -6.61.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-26 | 2025-12-31 | -6.61 | -5.72 |